Published in Proc Natl Acad Sci U S A on September 01, 1993
Helix-loop-helix proteins: regulators of transcription in eucaryotic organisms. Mol Cell Biol (2000) 8.89
E2A deficiency leads to abnormalities in alphabeta T-cell development and to rapid development of T-cell lymphomas. Mol Cell Biol (1997) 3.10
Regulation of G1 progression by E2A and Id helix-loop-helix proteins. EMBO J (1994) 2.33
Mitochondria-to-nuclear signaling is regulated by the subcellular localization of the transcription factors Rtg1p and Rtg3p. Mol Biol Cell (2000) 1.98
Mutations in TCF12, encoding a basic helix-loop-helix partner of TWIST1, are a frequent cause of coronal craniosynostosis. Nat Genet (2013) 1.82
Pivotal role for the NFIL3/E4BP4 transcription factor in interleukin 3-mediated survival of pro-B lymphocytes. Proc Natl Acad Sci U S A (1997) 1.82
Notch-induced E2A ubiquitination and degradation are controlled by MAP kinase activities. EMBO J (2003) 1.73
Insulin gene transcription is mediated by interactions between the p300 coactivator and PDX-1, BETA2, and E47. Mol Cell Biol (2002) 1.61
Domains with transcriptional regulatory activity within the ALL1 and AF4 proteins involved in acute leukemia. Proc Natl Acad Sci U S A (1995) 1.58
The homeodomain of PDX-1 mediates multiple protein-protein interactions in the formation of a transcriptional activation complex on the insulin promoter. Mol Cell Biol (2000) 1.55
Ectopic expression of E47 or E12 promotes the death of E2A-deficient lymphomas. Proc Natl Acad Sci U S A (1999) 1.53
Genes that confer the identity of the renin cell. J Am Soc Nephrol (2011) 1.52
Transformation properties of the E2a-Pbx1 chimeric oncoprotein: fusion with E2a is essential, but the Pbx1 homeodomain is dispensable. Mol Cell Biol (1994) 1.51
The AD1 transactivation domain of E2A contains a highly conserved helix which is required for its activity in both Saccharomyces cerevisiae and mammalian cells. Mol Cell Biol (1996) 1.39
The X protein of hepatitis B virus coactivates potent activation domains. Mol Cell Biol (1995) 1.36
Common regulation of growth arrest and differentiation of osteoblasts by helix-loop-helix factors. Mol Cell Biol (2001) 1.25
Functional characterization of the transactivation properties of the PDX-1 homeodomain protein. Mol Cell Biol (1997) 1.21
A network of broadly expressed HLH genes regulates tissue-specific cell fates. Cell (2011) 1.20
DNA-binding and transcriptional regulatory properties of hepatic leukemia factor (HLF) and the t(17;19) acute lymphoblastic leukemia chimera E2A-HLF. Mol Cell Biol (1994) 1.14
The NeuroD1/BETA2 sequences essential for insulin gene transcription colocalize with those necessary for neurogenesis and p300/CREB binding protein binding. Mol Cell Biol (1999) 1.08
Promotion of cell cycle progression by basic helix-loop-helix E2A. Mol Cell Biol (2001) 1.08
E2A-HLF-mediated cell transformation requires both the trans-activation domains of E2A and the leucine zipper dimerization domain of HLF. Mol Cell Biol (1995) 0.99
Disrupted differentiation and oncogenic transformation of lymphoid progenitors in E2A-HLF transgenic mice. Mol Cell Biol (1999) 0.96
Critical role for a single leucine residue in leukemia induction by E2A-PBX1. Mol Cell Biol (2006) 0.86
HEB in the spotlight: Transcriptional regulation of T-cell specification, commitment, and developmental plasticity. Clin Dev Immunol (2012) 0.86
c-jun inhibits insulin control element-mediated transcription by affecting the transactivation potential of the E2A gene products. Mol Cell Biol (1995) 0.85
An activation domain of the helix-loop-helix transcription factor E2A shows cell type preference in vivo in microinjected zebra fish embryos. Mol Cell Biol (1996) 0.83
Mixed lineage kinase phosphorylates transcription factor E47 and inhibits TrkB expression to link neuronal death and survival pathways. J Biol Chem (2009) 0.82
The bHLH factors extramacrochaetae and daughterless control cell cycle in Drosophila imaginal discs through the transcriptional regulation of the Cdc25 phosphatase string. PLoS Genet (2014) 0.82
Cloning and functional characterisation of avian transcription factor E2A. BMC Immunol (2004) 0.82
Identification of Intragenic Exon Deletions and Duplication of TCF12 by Whole Genome or Targeted Sequencing as a Cause of TCF12-Related Craniosynostosis. Hum Mutat (2016) 0.81
Role for homodimerization in growth deregulation by E2a fusion proteins. Mol Cell Biol (2000) 0.79
Essential roles of Da transactivation domains in neurogenesis and in E(spl)-mediated repression. Mol Cell Biol (2012) 0.79
Differential involvement of E2A-corepressor interactions in distinct leukemogenic pathways. Nucleic Acids Res (2013) 0.79
Functional redundancy between the transcriptional activation domains of E2A is mediated by binding to the KIX domain of CBP/p300. Nucleic Acids Res (2014) 0.77
Distinct Caenorhabditis elegans HLH-8/twist-containing dimers function in the mesoderm. Dev Dyn (2012) 0.77
Recombinant genomes which express chloramphenicol acetyltransferase in mammalian cells. Mol Cell Biol (1982) 116.75
The leucine zipper: a hypothetical structure common to a new class of DNA binding proteins. Science (1988) 27.01
Rapid detection of octamer binding proteins with 'mini-extracts', prepared from a small number of cells. Nucleic Acids Res (1989) 22.73
A new DNA binding and dimerization motif in immunoglobulin enhancer binding, daughterless, MyoD, and myc proteins. Cell (1989) 21.54
The Rous sarcoma virus long terminal repeat is a strong promoter when introduced into a variety of eukaryotic cells by DNA-mediated transfection. Proc Natl Acad Sci U S A (1982) 20.55
How eukaryotic transcriptional activators work. Nature (1988) 19.34
Interactions between heterologous helix-loop-helix proteins generate complexes that bind specifically to a common DNA sequence. Cell (1989) 14.24
Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc. Science (1991) 12.00
Eukaryotic transcriptional regulatory proteins. Annu Rev Biochem (1989) 11.73
B lineage--specific interactions of an immunoglobulin enhancer with cellular factors in vivo. Science (1985) 9.73
Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5' flanking elements. Science (1985) 8.44
Evidence that the leucine zipper is a coiled coil. Science (1989) 8.00
The MyoD DNA binding domain contains a recognition code for muscle-specific gene activation. Cell (1990) 7.94
Protein-binding sites in Ig gene enhancers determine transcriptional activity and inducibility. Science (1987) 7.63
The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev (1990) 6.88
Separation of DNA binding from the transcription-activating function of a eukaryotic regulatory protein. Science (1986) 6.79
Functional activity of myogenic HLH proteins requires hetero-oligomerization with E12/E47-like proteins in vivo. Cell (1991) 6.48
TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer muE3 motif. Genes Dev (1990) 6.00
A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell (1990) 5.39
Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science (1990) 4.93
An inhibitory domain of E12 transcription factor prevents DNA binding in E12 homodimers but not in E12 heterodimers. Cell (1991) 4.80
daughterless, a Drosophila gene essential for both neurogenesis and sex determination, has sequence similarities to myc and the achaete-scute complex. Cell (1988) 3.94
Functional antagonism between c-Jun and MyoD proteins: a direct physical association. Cell (1992) 3.55
Transcription factor AP-4 contains multiple dimerization domains that regulate dimer specificity. Genes Dev (1990) 3.44
What determines the specificity of action of Drosophila homeodomain proteins? Cell (1990) 3.34
Diversity and specificity in transcriptional regulation: the benefits of heterotypic dimerization. Trends Biochem Sci (1991) 3.18
A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancer. Proc Natl Acad Sci U S A (1987) 3.08
Synergistic activation of the insulin gene by a LIM-homeo domain protein and a basic helix-loop-helix protein: building a functional insulin minienhancer complex. Genes Dev (1992) 2.86
Control of c-Jun activity by interaction of a cell-specific inhibitor with regulatory domain delta: differences between v- and c-Jun. Cell (1990) 2.86
Pan: a transcriptional regulator that binds chymotrypsin, insulin, and AP-4 enhancer motifs. Genes Dev (1990) 2.46
B-cell- and myocyte-specific E2-box-binding factors contain E12/E47-like subunits. Mol Cell Biol (1991) 2.28
Different requirements for formation of Jun: Jun and Jun: Fos complexes. Genes Dev (1989) 2.22
Pancreatic beta-cell-type-specific transcription of the insulin gene is mediated by basic helix-loop-helix DNA-binding proteins. Mol Cell Biol (1991) 2.04
Two related helix-loop-helix proteins participate in separate cell-specific complexes that bind the insulin enhancer. Mol Endocrinol (1991) 2.03
The cell type-specific octamer transcription factor OTF-2 has two domains required for the activation of transcription. EMBO J (1990) 2.01
A beta-cell-specific protein binds to the two major regulatory sequences of the insulin gene enhancer. Proc Natl Acad Sci U S A (1988) 2.00
Fos and Jun repress transcriptional activation by myogenin and MyoD: the amino terminus of Jun can mediate repression. Genes Dev (1992) 1.92
Consequences of heteromeric interactions among helix-loop-helix proteins. Cell Growth Differ (1993) 1.90
Acquisition of myogenic specificity by replacement of three amino acid residues from MyoD into E12. Science (1992) 1.87
A new transcriptional-activation motif restricted to a class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells. Mol Cell Biol (1993) 1.86
Cell-specific and ubiquitous factors are responsible for the enhancer activity of the rat insulin II gene. J Biol Chem (1991) 1.82
Individual protein-binding domains of the insulin gene enhancer positively activate beta-cell-specific transcription. Mol Cell Biol (1989) 1.61
Distribution and characterization of helix-loop-helix enhancer-binding proteins from pancreatic beta cells and lymphocytes. Nucleic Acids Res (1991) 1.51
A cDNA from a mouse pancreatic beta cell encoding a putative transcription factor of the insulin gene. Nucleic Acids Res (1990) 1.49
Subunit structure of cell-specific E box-binding proteins analyzed by quantitation of electrophoretic mobility shift. J Biol Chem (1992) 1.17
The chymotrypsin enhancer core. Specific factor binding and biological activity. J Biol Chem (1989) 1.12
Cell-specific expression of helix-loop-helix transcription factors encoded by the E2A gene. Nucleic Acids Res (1993) 0.95
Sequence of the cDNA encoding ITF-1, a positive-acting transcription factor. Nucleic Acids Res (1990) 0.90
Insulin-producing cells contain a cell-specific repressor activity that functions through multiple E-box sequences. DNA Cell Biol (1992) 0.83
Cell-specific expression controlled by the 5'-flanking region of insulin and chymotrypsin genes. Nature (1984) 8.65
Cell-specific expression of the rat insulin gene: evidence for role of two distinct 5' flanking elements. Science (1985) 8.44
Autoantigens targeted in systemic lupus erythematosus are clustered in two populations of surface structures on apoptotic keratinocytes. J Exp Med (1994) 8.21
Recommendations for the establishment of primary stroke centers. Brain Attack Coalition. JAMA (2000) 7.25
Elevated levels of mRNA can account for the trans-activation of human immunodeficiency virus. Proc Natl Acad Sci U S A (1986) 6.57
Randomized comparisons of radiotherapy and nitrosoureas for the treatment of malignant glioma after surgery. N Engl J Med (1980) 4.90
Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. J Neurosurg (1978) 4.55
Methadone maintenance vs 180-day psychosocially enriched detoxification for treatment of opioid dependence: a randomized controlled trial. JAMA (2000) 4.41
Cost-effectiveness of tissue plasminogen activator for acute ischemic stroke. NINDS rt-PA Stroke Study Group. Neurology (1998) 3.62
MARCKS is an actin filament crosslinking protein regulated by protein kinase C and calcium-calmodulin. Nature (1992) 3.49
Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death. J Exp Med (1996) 3.16
A mutational analysis of the insulin gene transcription control region: expression in beta cells is dependent on two related sequences within the enhancer. Proc Natl Acad Sci U S A (1987) 3.08
Rheumatoid arthritis associated autoantibodies in patients with synovitis of recent onset. Arthritis Res (2000) 3.03
Cleavage by granzyme B is strongly predictive of autoantigen status: implications for initiation of autoimmunity. J Exp Med (1999) 2.81
Regulation by phosphorylation of reversible association of a myristoylated protein kinase C substrate with the plasma membrane. Nature (1991) 2.60
Regulation of rat insulin 1 gene expression: evidence for negative regulation in nonpancreatic cells. Proc Natl Acad Sci U S A (1986) 2.57
Expressing a human proinsulin cDNA in a mouse ACTH-secreting cell. Intracellular storage, proteolytic processing, and secretion on stimulation. Cell (1983) 2.54
An analysis of dose-effect relationship in the radiotherapy of malignant gliomas. Int J Radiat Oncol Biol Phys (1979) 2.54
Specific cleavage of the 70-kDa protein component of the U1 small nuclear ribonucleoprotein is a characteristic biochemical feature of apoptotic cell death. J Biol Chem (1994) 2.51
Stroke: who's counting what? J Rehabil Res Dev (2001) 2.32
Caspase-2 is localized at the Golgi complex and cleaves golgin-160 during apoptosis. J Cell Biol (2000) 2.29
Effects of a worksite nonsmoking policy: evidence for increased cessation. Am J Public Health (1991) 2.27
Detection and incidence of specific species of spoilage bacteria on fish. II. Relative incidence of Pseudomonas putrefaciens and fluorescent pseudomonads on haddock fillets. Appl Microbiol (1968) 2.27
DNA-dependent protein kinase is one of a subset of autoantigens specifically cleaved early during apoptosis. J Exp Med (1995) 2.25
PRiSM Psychosis Study. Design limitations, questionable conclusions. Br J Psychiatry (1999) 2.17
Group B streptococci during pregnancy: a comparison of two screening and treatment protocols. Am J Obstet Gynecol (1998) 2.08
The caspase-3 precursor has a cytosolic and mitochondrial distribution: implications for apoptotic signaling. J Cell Biol (1998) 2.07
Vaccination against autoimmune mouse diabetes with a T-cell epitope of the human 65-kDa heat shock protein. Proc Natl Acad Sci U S A (1991) 1.97
Granzyme B directly and efficiently cleaves several downstream caspase substrates: implications for CTL-induced apoptosis. Immunity (1998) 1.88
High-dose barbiturate control of elevated intracranial pressure in patients with severe head injury. J Neurosurg (1988) 1.87
Surface blebs on apoptotic cells are sites of enhanced procoagulant activity: implications for coagulation events and antigenic spread in systemic lupus erythematosus. Proc Natl Acad Sci U S A (1996) 1.82
Non-Invasive detection of respiratory effort-related arousals (REras) by a nasal cannula/pressure transducer system. Sleep (2000) 1.82
Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma. Cancer Treat Rep (1983) 1.81
Neurotoxicity of commonly used antineoplastic agents (second of two parts). N Engl J Med (1974) 1.77
Sindbis virus induces apoptosis through a caspase-dependent, CrmA-sensitive pathway. J Virol (1998) 1.71
Individual protein-binding domains of the insulin gene enhancer positively activate beta-cell-specific transcription. Mol Cell Biol (1989) 1.61
Superior vena cava syndrome. The myth--the facts. Am Rev Respir Dis (1990) 1.60
The production of cerebrospinal fluid in man and its modification by acetazolamide. J Neurosurg (1966) 1.58
Clinical studies with 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea (NSC 79037). Cancer Res (1971) 1.57
Vibrios from fish pen slime which mimic Escherichia coli on violet red bile agar. Appl Microbiol (1970) 1.57
Recurrent transverse myelitis associates with anti-Ro (SSA) autoantibodies. Neurology (2004) 1.55
Hsp60 accelerates the maturation of pro-caspase-3 by upstream activator proteases during apoptosis. EMBO J (1999) 1.52
Distribution and characterization of helix-loop-helix enhancer-binding proteins from pancreatic beta cells and lymphocytes. Nucleic Acids Res (1991) 1.51
A cDNA from a mouse pancreatic beta cell encoding a putative transcription factor of the insulin gene. Nucleic Acids Res (1990) 1.49
Effect of low intensity monochromatic light therapy (890 nm) on a radiation-impaired, wound-healing model in murine skin. Lasers Surg Med (1998) 1.46
Long-term clinical outcome in the Bypass Angioplasty Revascularization Investigation Registry: comparison with the randomized trial. BARI Investigators. Circulation (2000) 1.45
Impaired liver regeneration in inducible nitric oxide synthasedeficient mice. Proc Natl Acad Sci U S A (1998) 1.44
Annexin V binds to viable B cells and colocalizes with a marker of lipid rafts upon B cell receptor activation. J Immunol (2000) 1.44
Multimodality therapy in advanced paranasal sinus carcinoma: superior long-term results. Cancer J Sci Am (1999) 1.42
Bcl-2-dependent oxidation of pyruvate dehydrogenase-E2, a primary biliary cirrhosis autoantigen, during apoptosis. J Clin Invest (2001) 1.40
Practice-related functional activation changes in a working memory task. Microsc Res Tech (2000) 1.38
Brain tubulin and actin cDNA sequences: isolation of recombinant plasmids. Nucleic Acids Res (1980) 1.35
A review of quality of life in Alzheimer's disease. Part 2: Issues in assessing drug effects. Pharmacoeconomics (1998) 1.34
Workplace compliance with a no-smoking law: a randomized community intervention trial. Am J Public Health (1992) 1.30
Ultraviolet light-induced keratinocyte apoptosis: a potential mechanism for the induction of skin lesions and autoantibody production in LE. Lupus (1997) 1.28
The Life Skills Profile: psychometric properties of a measure assessing function and disability in schizophrenia. Acta Psychiatr Scand (1991) 1.26
Community orientated treatment compared to psychiatric hospital orientated treatment. Soc Sci Med (1984) 1.24
Neurotoxicity of commonly used antineoplastic agents (first of two parts). N Engl J Med (1974) 1.20
Transcription factor BETA2 acts cooperatively with E2A and PDX1 to activate the insulin gene promoter. J Biol Chem (2000) 1.20
Threshold Assessment Grid (TAG): the development of a valid and brief scale to assess the severity of mental illness. Soc Psychiatry Psychiatr Epidemiol (2000) 1.20
A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model. Proc Natl Acad Sci U S A (1996) 1.19
The importance of anti-HLA-specific antibody strength in monitoring kidney transplant patients. Am J Transplant (2007) 1.19
Tumor necrosis factor alpha modifies agonist-dependent responses in human neutrophils by inducing the synthesis and myristoylation of a specific protein kinase C substrate. Proc Natl Acad Sci U S A (1990) 1.18
Subunit structure of cell-specific E box-binding proteins analyzed by quantitation of electrophoretic mobility shift. J Biol Chem (1992) 1.17
Atrial fibrillation and antithrombotic prophylaxis: a prospective meta-analysis. Lancet (1989) 1.16
African-American race and antibodies to topoisomerase I are associated with increased severity of scleroderma lung disease. Chest (1998) 1.14
Apoptosis in systemic lupus erythematosus. Clinical implications. Rheum Dis Clin North Am (2000) 1.14
The DNA mismatch repair enzyme PMS1 is a myositis-specific autoantigen. Arthritis Rheum (2001) 1.14
Genes and pseudogenes in a reiterated rat tRNA gene cluster. Nucleic Acids Res (1984) 1.13
Clearing the way to mechanisms of autoimmunity. Nat Med (2001) 1.13
Novel fragments of the Sjögren's syndrome autoantigens alpha-fodrin and type 3 muscarinic acetylcholine receptor generated during cytotoxic lymphocyte granule-induced cell death. Arthritis Rheum (2001) 1.12
Unexpected augmentation of mycophenolic acid pharmacokinetics in renal transplant patients receiving tacrolimus and mycophenolate mofetil in combination therapy, and analogous in vitro findings. Transpl Immunol (1997) 1.12
Cell type and differentiation dependent heterogeneity in retinoblastoma protein expression in SCID mouse fetuses. Cell Growth Differ (1992) 1.11
Sequential activation of three distinct ICE-like activities in Fas-ligated Jurkat cells. FEBS Lett (1996) 1.09
Level of sleepiness and total sleep time following various time in bed conditions. Sleep (1993) 1.08
Lymphogenous metastasis in the primary carcinoma of the fallopian tube. Gynecol Oncol (1994) 1.08
Barium appendicitis: fact or fancy? Report of a case and review of the literature. J Clin Gastroenterol (1987) 1.07
NOD mouse diabetes: the ubiquitous mouse hsp60 is a beta-cell target antigen of autoimmune T cells. J Autoimmun (1996) 1.07
Smoking reduction during pregnancy by a program of self-help and clinical support. Obstet Gynecol (1992) 1.06
NF-kappa B activates the HIV promoter in neurons. EMBO J (1993) 1.06
Eye examinations for VA patients with diabetes: standardizing performance measures. Int J Qual Health Care (2000) 1.05
"Coffee groups": a nine-year follow-up study. Am J Psychiatry (1980) 1.05
Functional characterization of mouse T lymphocytes with IgM-Fc receptors. I. Studies on ADCC and helper cell function. J Immunol (1979) 1.04
(-)-Spiro[1-azabicyclo[2.2.2]octane-3,5'-oxazolidin-2'-one], a conformationally restricted analogue of acetylcholine, is a highly selective full agonist at the alpha 7 nicotinic acetylcholine receptor. J Med Chem (2000) 1.04
Spontaneous rupture of the urinary bladder--delayed sequel of pelvic irradiation. A case report. S Afr Med J (1986) 1.04
Methotrexate pneumonitis induced by intrathecal methotrexate therapy: a case report with pharmacokinetic data. Cancer (1976) 1.03
The inhibition of apoptosis in myositis and in normal muscle cells. J Immunol (2000) 1.03
Granzyme B cleavage of autoantigens in autoimmunity. Cell Death Differ (2010) 1.03
Six-year clinical effect of donor bone marrow infusions in renal transplant patients. Transplantation (2001) 1.03
The effects of chimeric cells following donor bone marrow infusions as detected by PCR-flow assays in kidney transplant recipients. J Clin Invest (1997) 1.02
Scleroderma autoantigens are uniquely fragmented by metal-catalyzed oxidation reactions: implications for pathogenesis. J Exp Med (1997) 1.00
Control of apoptosis by proteases. Adv Pharmacol (1997) 1.00
Eustachian tube endoscopy in patients with chronic ear disease. Laryngoscope (2000) 0.99
mRNA for the rat uterine estrogen-induced protein. Translation in vitro and regulation by estrogen. J Biol Chem (1981) 0.99
Identification and characterization of transcriptional regulatory regions associated with expression of the human apolipoprotein E gene. J Biol Chem (1988) 0.99
Partial response to bevacizumab of an extensive cutaneous angiosarcoma of the face. Br J Dermatol (2010) 0.99
Isolation and characterization of cloned rat DNA fragment carrying tRNA genes. Nucleic Acids Res (1981) 0.98
Adenovirus L4-100K assembly protein is a granzyme B substrate that potently inhibits granzyme B-mediated cell death. Immunity (2001) 0.98